<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; CRM</title>
	<atom:link href="http://www.tapanray.in/tag/crm/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>‘e-detailing’: The Future of Pharmaceutical Sales?</title>
		<link>http://www.tapanray.in/e-detailing-the-future-of-pharmaceutical-sales/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=e-detailing-the-future-of-pharmaceutical-sales</link>
		<comments>http://www.tapanray.in/e-detailing-the-future-of-pharmaceutical-sales/#comments</comments>
		<pubDate>Sun, 29 Sep 2013 23:30:35 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[advantages]]></category>
		<category><![CDATA[askpfizer]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[CRM]]></category>
		<category><![CDATA[detailing]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[e-detailing]]></category>
		<category><![CDATA[effectiveness]]></category>
		<category><![CDATA[electronic]]></category>
		<category><![CDATA[future]]></category>
		<category><![CDATA[japanese]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pfizerline]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[productivity]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Representatives]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[traditional]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=3751</guid>
		<description><![CDATA[Pharmaceutical product detailing to doctors by Medical Representatives (MRs) is believed to fetch the single largest return on marketing investments by the pharmaceutical companies globally, as on date. At the same time, the pharma players, across the world, are increasingly &#8230; <a href="http://www.tapanray.in/e-detailing-the-future-of-pharmaceutical-sales/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/e-detailing-the-future-of-pharmaceutical-sales/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
